Avery M A, Mehrotra S, Bonk J D, Vroman J A, Goins D K, Miller R
Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University 38677, USA.
J Med Chem. 1996 Jul 19;39(15):2900-6. doi: 10.1021/jm960200e.
Novel antimalarial artemisinin analogs, 3-alkylartemisinins as well as 3-(arylalkyl)- and 3-(carboxyalkyl)artemisinins, were prepared via the synthetic intermediate 2. Formation of the N,N-dimethylhydrazones 5 and 24 and then regio- and chemoselective deprotonation followed by alkylation provided initially alkylated hydrazones that upon chromatography gave ketones 6-13 and 25-30. Direct ozonolysis of the ketones followed by in situ acidification lead directly to the formation of title compounds 14-21 and 31-36. The analogs were tested in vitro against W-2 and D-6 strains of Plasmodium falciparum and found to be in some cases much more active than the natural product (+)-artemisinin. The results were included in structure-activity relationship (CoMFA) studies for further analog design.
通过合成中间体2制备了新型抗疟青蒿素类似物,即3-烷基青蒿素以及3-(芳基烷基)-和3-(羧基烷基)青蒿素。形成N,N-二甲基腙5和24,然后进行区域和化学选择性去质子化,接着进行烷基化,最初得到烷基化腙,经色谱分离得到酮6-13和25-30。酮的直接臭氧分解,随后原位酸化,直接导致标题化合物14-21和31-36的形成。这些类似物在体外针对恶性疟原虫的W-2和D-6菌株进行了测试,发现在某些情况下比天然产物(+)-青蒿素活性高得多。结果被纳入构效关系(CoMFA)研究,以进行进一步的类似物设计。